We are live on ! Find out more
FCMI

Foresite Capital Management I Portfolio holdings

AUM $21.4M Turnover 0%
1-Year Est. Return 80.48%
This Fund
S&P 500
This Quarter Est. Return
-37.06%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.4M
AUM Growth
-$12.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
2.8 years
Top 10 Avg Time Held
2.8 years
Top 20 Avg Time Held
2.8 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TXG icon
1
10x Genomics
TXG
$9.31B
$21.4M 100%
750,000
– –
2019 Q4
11 quarters

Similar funds

Foresite Capital Management I's Q3 2022 Portfolio in Review

As of Q3 2022, Foresite Capital Management I held 1 position worth $21.4M, down 37% from $33.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Foresite Capital Management I opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management I's ten largest holdings make up 100% of its $21.4M portfolio in Q3 2022.
  • Foresite Capital Management I opened 0 new positions and closed 0 in Q3 2022.
  • Foresite Capital Management I's portfolio value fell 37% quarter-over-quarter to $21.4M.

Based on Foresite Capital Management I's 13F filing for Q3 2022, filed 14 Nov 2022.